Chlorazepate dipotassium in the treatment of anxiety associated with chronic gastrointestinal disease.
D000328:Adult; D000368:Aged; D001007:Anxiety / Q000150:complications / Q000188:drug therapy*; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000627:therapeutic use; D005260:Female; D005767:Gastrointestinal Diseases / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D001552:Benzazepines; D010919:Placebos; D014149:Tranquilizing Agents; D003975:Diazepam